Open AccessLipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
Author(s) -
Tracey G. Simon,
AnnSofi Duberg,
Soo Aleman,
Hannes Hagström,
Long H. Nguyen,
Hamed Khalili,
Raymond T. Chung,
Jonas F. Ludvigsson
Publication year - 2019
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m18-2753
Subject(s) - medicine , hepatocellular carcinoma , statin , hazard ratio , population , cumulative incidence , incidence (geometry) , cohort study , gastroenterology , prospective cohort study , hepatitis c , cohort , lower risk , confidence interval , environmental health , physics , optics
Whether statin type influences hepatocellular carcinoma (HCC) incidence or mortality in chronic hepatitis B or C virus infection is unknown.